Search

This month, we recap what we learned about AI spreadsheet tools, how phage funding has changed over the years, and the rise of phage research in Latin America! Hi phage friends! It’s been a while since I’ve written one of these — Jan has

How do we get our phage grants funded? We start by getting to know our program officers! Joe Campbell has played a key role in shaping phage research funding for the last decade during his time at NIAID, and this week shares how he sees the

This week, Jonathan Moore tells us how (and why) he founded nonprofit GSD Bio to build a lactococcal phage-based vaccine production system as a public good. “Among the many lessons of COVID-19, one of the most profound is this: You don’t ne

This week, Ruby CY Lin of Phage Australia dives further into commercialization pathways and opportunities for Phage Australia, and the phage industry as a whole. Welcome back to the third installment of the Sustainable Phage Therapy serie

This week, Ruby CY Lin of Phage Australia dives further into commercialization pathways and opportunities for Phage Australia, and the phage industry as a whole. In Part Two of this three-part series, she explores possible phage therapy in

This week, we're featuring a guest post by Raphael Hans Lwesya, MSc student at Makerere University in Uganda and founder of thephage.xyz, a new phage-related info hub. Raphael shares his thoughts on phage technology development in Africa, h

This week, Kyle Jackson (PhD student at McMaster University) brings us a profile of Adaptive Phage Therapeutics, the clinical-stage phage biotech company commercializing the US Navy's phage collection. This is the first in a new column Kyle

What brought phage therapy to where it is today? This week, we're featuring an interview with Dr. David Harper, CEO of Evolution Biotechnologies, by Curtis Hoffmann, a longtime Phage Directory volunteer. They discuss David's thoughts on his

This week, we bring you an interview with Dr. Richard Alm, Alliance Director at CARB-X, a major current funder of new antimicrobials, including phage! Richard shares how he sees phages fitting into the clinical landscape, and shares his adv

This week, Donna May Papa, Assistant Professor at the University of Santo Tomas in Manila, Philippines, tells us about her lab's journey into phage research, and their plans for the future. Since the global antimicrobial resistance crisis h

This week, a group of researchers led by Dr. Anthony Maresso at Baylor College of Medicine describe their new initiative, TAILΦR, which makes phages tailored to patients' infections. ## How did you first get involved with phage research? Wh

A look into government incentives for antimicrobial development, and how they apply to phage therapeutic development. If phage therapeutics are going to be developed as drugs, at least in the US, there needs to be significantly more investm